Delcath systems stock price

16 Jul 2018 Delcath Systems Announces Rights Offering and Backstop Commitment shares of common stock at the subscription price of $1.75 per share. 20 Jun 2017 Delcath Systems, Inc. (NASDAQ: DCTH) is having yet another incredible day in the market today. Investors seem to be putting full faith and  11 Sep 2017 Delcath Systems, Inc. (NASDAQ: DCTH) is having a relatively strong start in the pre-market trading hours this morning. However, at the moment 

Real time Delcath Systems (DCTH) stock price quote, stock graph, news & analysis. DCTHD - Delcath Systems Stock Price - Barchart.com Delcath Systems Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. DCTH Stock | DELCATH SYSTEMS Stock Price Today | Markets ...

Should I buy Delcath Systems, Inc. (DCTH) - Zacks

Mar 28, 2018 · Delcath Systems, Inc. (OTCMKTS: DCTH) is a company that I’ve covered quite a bit over the course of several months. The company caught my … DCTH Stock Price & Charts | Delcath Systems In depth view into DCTH (Delcath Systems) stock including the latest price, news, dividend history, earnings information and financials. DCTH: Delcath Systems Inc - Stock Price, Quote and News - CNBC Get Delcath Systems Inc (DCTH:OTCQB) real-time stock quotes, news and financial information from CNBC. DCTH - Delcath Systems Inc Stock quote - CNNMoney.com

Company Releases for Delcath Systems Inc. Friday, March 13, 2020. 03:06 AM ET. Bile Duct Cancer Therapeutics Market 2020 Size, Global Trends, Comprehensive Research Study, Development Status, Opportunities, Future Plans, Competitive Landscape and Growth by Forecast 2026 Profound. Thursday, February 27, 2020

Historical Prices - Delcath Systems Inc. Name (required) Email (required) Message (required) Please leave this field empty. DCTH Stock Price and Chart — OTC:DCTH — TradingView Delcath Systems, Inc. is an oncology company, which focuses on the treatment of primary and metastatic liver cancers. It develops and commercializes CHEMOSAT and Melphalan Hydrochloride for Injection, which is a proprietary product used with the Delcath Hepatic Delivery System. DCTH - Delcath Systems Stock Profile - Barchart.com Price/Sales - Latest closing price of the stock divided by the last twelve months revenue/sales per share. Price/Cash Flow - Latest closing price of the stock divided by the last twelve months revenue/cash flow per share. Price/Book - A financial ratio used to compare a company's current market price …

: Get the latest Delcath Systems stock price and detailed information including news, historical charts and realtime prices.

Name (required) Email (required) Message (required) Please leave this field empty. DCTH Stock Price and Chart — OTC:DCTH — TradingView

Delcath Systems (DCTH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

7 Jun 2016 PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with  27 Jun 2014 Delcath is a specialty pharmaceutical and medical device company focused on oncology. Delcath common stock is listed on the NASDAQ. 13 Oct 2016 SAT - 5 - Delcath Systems: Percutaneous Hepatic Perfusion (Zager). Ocular Melanoma Foundation. Loading Unsubscribe from Ocular  7 Oct 2015 our host spoke with Jennifer K. Simpson, Ph.D., MSN, CRNP, President and CEO of Delcath Systems, Inc. (NASDAQ: DCTH) in New York DCTH Stock Price | Delcath Systems Inc. Stock Quote (U.S ...

In depth view into DCTH (Delcath Systems) stock including the latest price, news, dividend history, earnings information and financials. DCTH: Delcath Systems Inc - Stock Price, Quote and News - CNBC Get Delcath Systems Inc (DCTH:OTCQB) real-time stock quotes, news and financial information from CNBC.